Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settings.

Journal of hepatology - 1 Nov 2014

Ford Nathan, Swan Tracy, Beyer Peter, Hirnschall Gottfried, Easterbrook Philippa, Wiktor Stefan

Abstract excerpt

Currently, access to treatment for HCV is limited, with treatment rates lowest in the more resource-limited countries, including those countries with the highest prevalence. The use of oral DAAs has the potential to provide treatment at scale by offering opportunities to simplify drug regimens, laboratory requirements, and service delivery models. Key desirable characteristics of future HCV treatment regimens...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Delivery of Health Care

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Developing Countries

Share to Health Care Costs

Share to Health Services Accessibility

Share to Hepatitis C

Share to Public Health

Share to World Health Organization

Source

Identifiers

PMID: 25443341
DOI: 10.1016/j.jhep.2014.09.019

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settings.PMID 25443341Read ↗

Pan‐genotypic treatment regimens for hepatitis C virus: Advantages and disadvantages in high‐ and low‐income regionsSemantic proximity Read ↗

New hepatitis C therapies: the toolbox, strategies, and challenges.Semantic proximity Read ↗

The hepatitis C revolution part 1: antiviral treatment options.Semantic proximity Read ↗

Oral Combination Therapies for Hepatitis C Virus Infection: Successes, Challenges, and Unmet Needs.Semantic proximity Read ↗

Novel therapies for hepatitis C - one pill fits all?Semantic proximity Read ↗

Cost effectiveness of hepatitis C direct acting agents.Semantic proximity Read ↗

Current therapy for chronic hepatitis C: The role of direct-acting antivirals.Semantic proximity Read ↗

Challenges and perspectives of direct antivirals for the treatment of hepatitis C virus infection.Semantic proximity Read ↗

Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial.Semantic proximity Read ↗

Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care Providers.Semantic proximity Read ↗

Revolutionizing treatment outcomes in hepatitis C: managed care implications and considerations--diagnosis and management.Semantic proximity Read ↗

Hepatitis C virus elimination: So close, so far?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.